Gilles Salles, MD, PhD | Authors


How Will New Immunotherapies Fit Into the Treatment Landscape of Follicular Lymphoma?

October 04, 2022

Future directions for follicular lymphoma treatments include potential use earlier in treatment or as combination therapy, identifying patients who will benefit most from treatment, and minimizing the costs of therapy while maximizing accessibility.

Available Third-Line Treatment Regimens in R/R DLBCL

August 12, 2022

Dr Salles provides an overview of the available third-line treatment options for patients with R/R DLBCL who are ineligible for or do not wish to receive autologous stem cell transplant or CAR T-cell therapy.